Jump to resource

Projects. Life and Matter Sciences

The molecular bases of disease: biointeractomics of programmed cell death

Lead Researcher:
Miguel Ángel De la Rosa Acosta

Research Centre:
cicCartuja, Instituto de Bioquímica Vegetal y Fotosíntesis. Universidad de Sevilla-CSIC.


Miguel Ángel De la Rosa AcostaThe control of cell survival and death is essential for cellular homeostasis, and dysfunction of the latter causes many diseases. This project aims to characterise the network of interactions between proteins (or biointeractome) by focusing on cytochromec, which regulates programmed cell death (or apoptosis). The activation of Apaf-1 (apoptotic protease activating factor 1) in cytoplasm was until very recently the only known function of cytochrome c released by the mitochondria, but recent findings by our group indicate that the haemoprotein is the key node in a biointeractomic network conserved in the evolution of plants and humans (Martínez Fábregas et al., 2013; 2014). The aforementioned pro-apoptotic biointeractome spreads in the cytoplasm and nucleus until it interferes with regulation of the p53 tumour suppressor. We therefore aim to analyse the interactions of cytochrome c with the aforementioned target proteins that regulate p53 in structural and functional terms, using the techniques available in the recently created Plataforma de Interacciones Biomoleculares del cicCartuja.

Given that cytochrome c suffers post-translational modifications which alter its structure and function, we also intend to determine how the phosphorylation of certain thyrosines modifies the affinity of cytochrome c for its new targets. In this way, the goal is to construct the biointeractomic network of phosphorylated cytochrome c, the result of which will be validated by transverse biophysical techniques, an innovative approach used with success by our team in previous studies (www.ibvf.csic.es/en/biointeractomics).

The execution of the proposed tasks will make it possible to determine common epitopes at the sites where cytochrome c binds to its new apoptotic targets and, likewise, learn more about the molecular bases of diseases, above all neurodegenerative ones and cancer, thereby opening up a new route for the design of new drugs.

Miguel Ángel De la Rosa Acosta

Professor in the University of Seville and director of the Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), a mixed centre of the Universidad Hispalense, the Consejo Superior de Investigaciones Científicas (CSIC) and the Junta de Andalucía.

He researches in the Instituto de Bioquímica Vegetal y Fotosíntesis (Seville), which is a part of cicCartuja, in the field of structural biology and bioorganic chemistry. He is the author or co-author of four books, holds two patents, and has published about one hundred and seventy papers in high impact scientific journals and numerous educational and viewpoint contributions in the press. He has given about one hundred and fifty lectures in Europe, America, Asia and Africa.

He has been the President of the Federación Europea (FEBS) and the Sociedad Española (SEBBM) de Bioquímica y Biología Molecular, as well as the Bioelectrochemical Society. He is editor-in-chief of the journal SEBBM, and editor of the journals IUBMB Life, FEBS Letters, FEBS OpenBio and Bioelectrochemistry. He is a member elect of the Real Academia de Ciencias of Seville, he has been a member of the jury for the Rey Jaime I Prize, and he was awarded the I Javier Benjumea Puigcerver Prize for Research (Fundación Focus-Abengoa).

*All intellectual property rights belong to the author. Reproduction of all or part of the work without permission from the author is prohibited.
© RAMÓN ARECES FOUNDATION. All rights reserved.

Síguenos en

  • Twitter
  • Facebook
  • Flickr
  • Youtube
  • Slideshare

© 2007 Fundación Ramón Areces All rights reserved.

c/ Vitruvio, 5. 28006 Madrid (España) | Telephone: 91 515 89 82 | C.I.F.: G-28459311